UBS’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $5.32M | Buy |
3,550
+1,205
| +51% | +$1.81M | ﹤0.01% | 1485 |
|
|
2014
Q2 | $3.21M | Buy |
2,345
+1,110
| +90% | +$1.52M | ﹤0.01% | 1853 |
|
|
2014
Q1 | $1.72M | Buy |
1,235
+398
| +48% | +$553K | ﹤0.01% | 2235 |
|
|
2013
Q4 | $833K | Sell |
837
-193
| -19% | -$192K | ﹤0.01% | 2715 |
|
|
2013
Q3 | $1.07M | Buy |
1,030
+15
| +1% | +$15.6K | ﹤0.01% | 2396 |
|
|
2013
Q2 | $1.11M | Buy |
+1,015
| New | +$1.11M | ﹤0.01% | 2315 |
|